Scarica l'app Stockscreener
3.59
4.01%
-0.15
Dopo l'orario di chiusura:
3.55
-0.04
-1.11%
Precedente Chiudi:
$3.74
Aprire:
$3.6
Volume 24 ore:
16,012
Relative Volume:
0.07
Capitalizzazione di mercato:
$85.98M
Reddito:
$48.20M
Utile/perdita netta:
$-35.05M
Rapporto P/E:
-2.2906
EPS:
-1.5673
Flusso di cassa netto:
$-13.02M
1 W Prestazione:
+67.76%
1M Prestazione:
+78.61%
6M Prestazione:
+56.09%
1 anno Prestazione:
+21.69%
Intervallo 1D:
$3.52
$3.70
Intervallo di 1 settimana:
$2.0319
$4.35
Portata 52W:
$1.06
$5.22
Celularity Inc Stock (CELU) Company Profile
Nome
Celularity Inc
Settore
Industria
Telefono
(908) 768-2170
Indirizzo
170 PARK AVE, FLORHAM PARK
Confronta CELU con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
3.59 | 89.57M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-30 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-06-22 | Iniziato | H.C. Wainwright | Buy |
| 2022-04-06 | Downgrade | Truist | Buy → Hold |
| 2022-01-28 | Iniziato | Oppenheimer | Outperform |
| 2021-11-24 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Celularity Inc Borsa (CELU) Ultime notizie
What drives Celularity Inc. stock priceTriple-digit return opportunities - Autocar Professional
Is Celularity Inc. a good long term investmentExponential wealth increase - Autocar Professional
What drives Celularity Inc. Equity Warrant stock priceBreakthrough profits - Autocar Professional
What analysts say about Celularity Inc. stockTriple-digit wealth increases - Autocar Professional
Is Celularity Inc. Equity Warrant a good long term investmentOutstanding capital returns - jammulinksnews.com
What analysts say about Celularity Inc. Equity Warrant stockPhenomenal wealth increase - jammulinksnews.com
Celularity Finalizes Private Placement Agreement - TipRanks
Celularity Soared 23.8% Intraday, Could This Biotech Breakout Signal a New Bullish Era? - AInvest
Celularity Inc. Equity Warrant Stock Analysis and ForecastOutstanding capital growth - Autocar Professional
Will Celularity Inc. Equity Warrant stock benefit from AI tech trendsCarefully Curated High Return Stocks - Newser
Celularity Stock Surges Over 8% Amid Florida Stem Cell Policy, New Partnership Boost - AInvest
Why Celularity Inc. Equity Warrant stock attracts strong analyst attentionInsider Strategy Insight - beatles.ru
Celularity Inc. Plunges 16.94% Amid Volatile Trading - AInvest
What makes Celularity Inc. stock price move sharplyRapid Gain Targets - Newser
Celularity Stock: Time to Reconsider? - StocksToTrade
Celularity Inc (CELU) Stock: A Year of Market Fluctuations - investchronicle.com
How Celularity Inc. Equity Warrant stock performs during market volatility3x Growth Potential - Newser
How Celularity Inc. stock performs during market volatilitySecure Your Capital Strategy - Newser
What makes Celularity Inc. Equity Warrant stock price move sharplyFree Access to Community with 300% Return - Newser
Why Celularity Inc. stock attracts strong analyst attentionFree Stock Tips Group - Newser
Celularity Inc Azioni (CELU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Celularity Inc Azioni (CELU) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hariri Robert J | Chief Executive Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
3,281 |
0 |
21,482 |
| Haines John R | Senior Exec Vice President |
Apr 13 '25 |
Option Exercise |
0.00 |
1,641 |
0 |
29,698 |
| Beers David C | Chief Financial Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
1,025 |
0 |
18,561 |
| Brigido Stephen | Pres., Functional Regeneration |
Feb 17 '25 |
Option Exercise |
0.00 |
10,000 |
0 |
11,641 |
| Beers David C | Chief Financial Officer |
Feb 17 '25 |
Option Exercise |
0.00 |
12,500 |
0 |
21,932 |
| Haines John R | Senior Exec Vice President |
Feb 17 '25 |
Option Exercise |
0.00 |
20,000 |
0 |
35,092 |
4.91%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):